Nilutamide Articles
HMR Launch Nilandron For Prostate Cancer
7 October 1996
Roussel-Uclaf Details Group Pipeline Plans
10 April 1995
Anandron Vote Overrules FDA Reviewer
6 March 1995
Zeneca Gets First Approval For Casodex
6 March 1995
Showing 1-5 of 5 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
